Abstract

Introduction: WHO recommends that all infants should be exclusively breastfed for six months after birth. However, practices in India are largely influenced by traditional family practices, knowledge and attitude towards breastfeeding among the population and this study was planned to assess factors associated with breastfeeding among women in Delhi.

Highlights

  • We reported in 1994, the ability of a vaccine developed against hCG to prevent pregnancy in sexually active women of proven fertility [1]

  • Approval has been received from the Drugs Controller General of India and Institutional Ethics Committees to conduct these trials at the All India Institute of Medical Sciences and Sir Gangaram Hospital New Delhi

  • HCG or its subunits have been reported to be expressed in a variety of nontrophoblastic cancers such as lung cancer [3], bladder carcinoma [4], colorectal carcinoma [5], pancreatic carcinoma [6], breast cancer [7], cervical carcinoma [8], oral cancers [9], vulva⁄vaginal cancers [10], prostate cancer [11] and gastric carcinomas [12]

Read more

Summary

Crimson Publishers Wings to the Research

Volume 3 - Issue 3 How to cite this article: Talwar GP, Gupta Jagdish C. All women continued to ovulate as was evident from luteal phase progesterone. They continued to have regular Menstrual cycles. This vaccine has been converted to a genetically engineered vaccine so that it is amenable to industrial production. A new feature of this vaccine will be the use of both the DNA and protein form of the vaccine. The previously reported vaccine heralded the encouraging possibility of birth control without any derangement of ovulation, hormonal profiles and menstrual regularity. Let us hope that the genetically engineered version of the same vaccine retains the same properties

Perception in Reproductive Medicine
Findings
Perceptions Reprod Med
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call